Orthex (ORTHEX) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
26 Dec, 2025Executive summary
Net sales grew 4.4% year-over-year to EUR 89.7 million, with strong growth outside the Nordics and resilient performance in a sluggish market.
Invoiced sales reached EUR 92.3 million, with Rest of Europe up 10% and Nordics up 3.5% year-over-year.
Adjusted EBITA for the year was EUR 10.2 million, with a margin of 11.4%, impacted by higher costs and absence of prior year one-off support.
Investments of EUR 4.3 million focused on new product lines, capacity, and sustainability initiatives, including joining the Circular Economy Green Deal.
Board proposes a dividend of EUR 0.22 per share, totaling approximately EUR 3.9 million, to be paid in two instalments.
Financial highlights
Q4 net sales reached a record EUR 23.9 million, up 2% year-over-year, with international sales outside the Nordics growing by 10%.
Adjusted EBITDA for 2024 was EUR 14.6 million; adjusted EBITA margin declined to 11.4% from 12.7%.
Net cash flows from operating activities improved to EUR 11.8 million, up 16.1% year-over-year.
Net debt/Adjusted EBITDA improved to 1.4x from 1.5x; equity ratio rose to 41.9%.
Operating profit for 2024 was EUR 9.8 million; profit for the period was EUR 6.1 million.
Outlook and guidance
Market recovery remains sluggish, with continued consumer focus on low prices and ongoing market turbulence.
Long-term targets: annual organic net sales growth >5% (group), >10% (outside Nordics), adjusted EBITA margin >18%, leverage <2.5x, and pay-out ratio >50%.
No short-term outlook published; international sales organization strengthening to support further growth in Europe.
Raw material prices stabilized in 2024; 2025 prices will depend on demand, sanctions, and logistics.
Latest events from Orthex
- Profitability and cash flow improved despite lower sales, supporting a higher dividend proposal.ORTHEX
Q4 20255 Mar 2026 - Net sales up 5.9% to €43.0m, with Storage and Kitchen driving growth and leverage at 1.6.ORTHEX
Q2 202423 Jan 2026 - Net sales up 5.3% year-over-year, but profitability declined amid higher costs.ORTHEX
Q3 202413 Jan 2026 - Sales and profit declined, but cash flow and sustainability progress remained strong.ORTHEX
Q1 202527 Nov 2025 - H1 2025 sales fell 3.5% but margins and European growth improved despite Nordic weakness.ORTHEX
Q2 202523 Nov 2025 - Record Q3 sales and higher margins offset a weak start, with strong cash flow and ESG gains.ORTHEX
Q3 202513 Nov 2025